EUVIMEDEUVIMED entdecken
Crossref

Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer’s disease biomarkers

Alice Ballerini iD, Niccolò Biagioli, Chiara Carbone, Annalisa Chiari, Manuela Tondelli, Giulia Vinceti, Roberta Bedin, Marcella Malagoli, Maurilio Genovese, Simona Scolastico, Giada Giovannini, Matteo Pugnaghi und 5 weitere

Brain · 2025

DOI: 10.1093/brain/awae207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Alice Ballerini und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Atrophy, Epilepsy, Temporal Lobe, Biomarkers. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Emilia-Romagna Region health, Ministry of University and Research, PRIN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Considering the growing age of the world population, the incidence of epilepsy in older adults is expected to increase significantly. It has been suggested that late-onset temporal lobe epilepsy (LO-TLE) may be neurodegenerative in origin and overlap with Alzheimer’s disease (AD). Herein, we aimed to characterize the pattern of cortical atrophy and CSF biomarkers of AD (total and phosphorylated tau and amyloid-β) in a selected population of LO-TLE of unknown origin. We prospectively enrolled individuals with temporal lobe epilepsy onset after the age of 50 and no cognitive impairment. They underwent a structural MRI scan and CSF biomarkers measurement. Imaging and biomarkers data were compared to three retrospectively collected groups: (i) age-sex-matched healthy controls; (ii) patients with mild cognitive impairment (MCI) and abnormal CSF AD biomarkers (MCI-AD); and (iii) patients with MCI and normal CSF AD biomarkers (MCI-noAD). From a pool of 52 patients, 20 consecutive eligible LO-TLE patients with a mean disease duration of 1.8 years were recruited. As control populations, 25 patients with MCI-AD, 25 patients with MCI-noAD and 25 healthy controls were enrolled. CSF biomarkers returned normal values in LO-TLE, significantly different from patients with MCI due to AD. There were no differences in cortico-subcortical atrophy between epilepsy patients and healthy controls, while patients with MCI demonstrated widespread injuries of cortico-subcortical structures. Individuals with LO-TLE, characterized by short disease duration and normal CSF amyloid-β and tau protein levels, showed patterns of cortical thickness and subcortical volumes not significantly different from healthy controls, but highly different from patients with MCI, either due to AD or not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAtrophyEpilepsy, Temporal LobeBiomarkersAmyloid beta-Peptidestau ProteinsMagnetic Resonance ImagingHumansFemaleMaleMiddle AgedAgedCognitive DysfunctionBrainAge of OnsetRetrospective Studies

Stichwörter der Autor:innen

CSF biomarkersamyloid-βlate-onset temporal lobe epilepsymild cognitive impairmentphosphorylated taustructural MRI

Substanzen

BiomarkersAmyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Neuroscience Department, Neurology Unit, OCB Hospital, AOU Modena, 41126 Modena, Italy.
  • Neuroscience Department, Neuroradiology Unit, OCB Hospital, AOU Modena, 41126 Modena, Italy.
  • Neuroscience Department, Neurophysiology Unit and Epilepsy Centre, AOU Modena, 41126 Modena, Italy.
  • Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London WC1N 3BG, UK.

ORCID-Profile: Alice Ballerini, Stefano Meletti, Giovanna Zamboni, Anna Elisabetta Vaudano

Förderung

  • Emilia-Romagna Region health
  • Ministry of University and Research
  • PRIN

Zitieren

APA

Ballerini, A., Biagioli, N., Carbone, C., Chiari, A., Tondelli, M., Vinceti, G., Bedin, R., Malagoli, M., Genovese, M., Scolastico, S., Giovannini, G., Pugnaghi, M., Orlandi, N., Lemieux, L., Meletti, S., Zamboni, G., & Vaudano, A. E. (2025). Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer’s disease biomarkers. Brain. https://doi.org/10.1093/brain/awae207

Vancouver

Ballerini A, Biagioli N, Carbone C, Chiari A, Tondelli M, Vinceti G, et al. Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer’s disease biomarkers. Brain. 2025. doi:10.1093/brain/awae207

BibTeX
@article{Ballerini2025,
  author = {Ballerini, Alice and Biagioli, Niccolò and Carbone, Chiara and Chiari, Annalisa and Tondelli, Manuela and Vinceti, Giulia and Bedin, Roberta and Malagoli, Marcella and Genovese, Maurilio and Scolastico, Simona and Giovannini, Giada and Pugnaghi, Matteo and Orlandi, Niccolò and Lemieux, Louis and Meletti, Stefano and Zamboni, Giovanna and Vaudano, Anna Elisabetta},
  title = {Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer’s disease biomarkers},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awae207}
}
Kostenlos starten →